- Home
- TALK vs SIGA Comparison
TALK vs SIGA Comparison
Compare TALK & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TALK
- SIGA
- Stock Information
- Founded
- TALK 2012
- SIGA 1995
- Country
- TALK United States
- SIGA United States
- Employees
- TALK N/A
- SIGA N/A
- Industry
- TALK Medical/Nursing Services
- SIGA Biotechnology: Pharmaceutical Preparations
- Sector
- TALK Health Care
- SIGA Health Care
- Exchange
- TALK Nasdaq
- SIGA Nasdaq
- Market Cap
- TALK 534.6M
- SIGA 443.4M
- IPO Year
- TALK N/A
- SIGA 1997
- Fundamental
- Price
- TALK $3.01
- SIGA $5.91
- Analyst Decision
- TALK Buy
- SIGA
- Analyst Count
- TALK 5
- SIGA 0
- Target Price
- TALK $4.38
- SIGA N/A
- AVG Volume (30 Days)
- TALK 2.6M
- SIGA 401.8K
- Earning Date
- TALK 02-20-2025
- SIGA 03-11-2025
- Dividend Yield
- TALK N/A
- SIGA 10.16%
- EPS Growth
- TALK N/A
- SIGA N/A
- EPS
- TALK 0.01
- SIGA 1.20
- Revenue
- TALK $187,593,000.00
- SIGA $173,731,386.00
- Revenue This Year
- TALK $28.27
- SIGA $16.79
- Revenue Next Year
- TALK $23.44
- SIGA $15.08
- P/E Ratio
- TALK $442.17
- SIGA $4.94
- Revenue Growth
- TALK 25.02
- SIGA 399.31
- 52 Week Low
- TALK $1.60
- SIGA $4.75
- 52 Week High
- TALK $4.36
- SIGA $12.83
- Technical
- Relative Strength Index (RSI)
- TALK 36.07
- SIGA 43.23
- Support Level
- TALK $2.94
- SIGA $5.80
- Resistance Level
- TALK $4.36
- SIGA $6.25
- Average True Range (ATR)
- TALK 0.30
- SIGA 0.23
- MACD
- TALK -0.07
- SIGA 0.01
- Stochastic Oscillator
- TALK 5.92
- SIGA 43.44
About TALK Talkspace Inc.
Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue primarily stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.